Radiation therapy or chemoradiation therapy for lung cancer and esophageal cancer

M.B., 1995.9-2000.7 Sun-Yat-Sen University, Guangzhou, P.R. China

M.S., 2003.9-2006.9 Cancer Center, Sun-Yat-Sen University, Guangzhou, P.R. China, 

Ph. D of Radiation Oncology, 2006.9-2009.12  Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, P.R. China.

 Li QQ, Swanick CW, Pamela KA, et al. Exploration of stereotactic ablative radiotherapy (SABR) using 70Gy in 10 fractions for non-small cell lung cancer: what are the indication? Radiother Oncol, 2014 (accepted)

 Chang JY, Li QQ, Xu QY, et al. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a “no fly zone”. Int J Radiat Oncol Biol Phys, 2014, 88: 1120-1128.

 Lei Z, Li QQ (equal contributors), Rui Z, et al. The overexpression of IGFBP-3 is involed in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin. Tumor Biology, 2012, 33:1115-1123. 

 Li QQ, Liu MZ, Hu YH, Liu H, He ZY, Lin HX. Definitive concomitant chemoradiotherapy with docetaxel and cisplatin in squamous esophageal carcinoma. Dis Esophagus. 2010, 23(3):253-9.

 Li QQ, Hu YH, Liu MZ, Liu H, Huang Y, He ZY, Lin HX. Results of radiotherapy with concurrent docetaxel and cisplatin in unresectabel esophageal carcinoma. Chin J Radiat Oncol, 2009, 18(5): 379-382.

 Li QQ, Liu MZ, Hu YH, Liu H, Huang Y, Cui NJ. Clinical Value of Barium Swallow in Observing Esophageal Tumor Regression during Radiotherapy. Chin J Cancer, 2003, 25(6):723-727.

 

Last Updated on: August 2014 by International Office, Sun Yat-sen University Cancer Center